Production of extracellular l-asparaginase: from bioprospecting to the engineering of an antileukemic biopharmaceutical

Abstract

L-asparaginase is an enzyme clinically accepted as an anti-tumor agent for the treatment of acute lymphoblastic leukemia and lymphosarcoma. The main focus of this study is to provide a thorough overview on microbial production of such a biopharmaceutical